We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$702M
AUM Growth
-$200M
Cap. Flow
-$80.1M
Cap. Flow %
-11.41%
Top 10 Hldgs %
28.8%
Holding
103
New
24
Increased
13
Reduced
18
Closed
33

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$19.1M
2
AMD icon
Advanced Micro Devices
AMD
+$18M
3
FTAI icon
FTAI Aviation
FTAI
+$15.3M
4
APG icon
APi Group
APG
+$14.9M
5
CYTK icon
Cytokinetics
CYTK
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 24.98%
2 Miscellaneous 16.64%
3 Industrials 15.4%
4 Technology 11.23%
5 Consumer Discretionary 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.49B
$28.5M 4.06%
790,547
+260,547
+49% +$8.81M
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.74B
$26.4M 3.77%
2,000,000
+1,000,000
+100% +$17.1M
PRAX icon
3
Praxis Precision Medicines
PRAX
$9.63B
$23.3M 3.32%
303,000
-65,000
-18% -$4.7M
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$22.1M 3.15%
+100,000
New +$22.8M
THC icon
5
Tenet Healthcare
THC
$21.5B
$19.1M 2.73%
151,700
-14,522
-9% -$2.16M
CRH icon
6
CRH
CRH
$63.8B
$17.1M 2.44%
185,000
ECG
7
Everus Construction Group
ECG
$5.91B
$17.1M 2.44%
+260,000
New +$16.4M
TAP icon
8
Molson Coors Class B
TAP
$7.73B
$16.5M 2.35%
288,200
ONON icon
9
On Holding
ONON
$9.64B
$16.4M 2.34%
300,000
+20,000
+7% +$1.06M
INSM icon
10
Insmed
INSM
$25.9B
$15.5M 2.21%
225,000
-175,000
-44% -$12.6M
MMM icon
11
3M
MMM
$89.9B
$14.8M 2.11%
115,000
-25,000
-18% -$3.28M
TSM icon
12
TSMC
TSM
$2.17T
$14.8M 2.11%
75,000
+10,000
+15% +$1.94M
IP icon
13
International Paper
IP
$20.8B
$14.8M 2.11%
275,000
-25,000
-8% -$1.34M
SPY icon
14
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$14.7M 2.09%
25,000
-125,000
-83% -$73.6M
HEI icon
15
HEICO Corp
HEI
$47B
$14.3M 2.03%
60,000
+5,000
+9% +$1.3M
CRL icon
16
Charles River Laboratories
CRL
$13.9B
$14M 1.99%
75,700
+1,600
+2% +$308K
SAIA icon
17
Saia
SAIA
$9.37B
$13.7M 1.95%
30,000
-2,500
-8% -$1.24M
CART icon
18
Maplebear
CART
$11.7B
$13.3M 1.89%
+320,000
New +$13.9M
META icon
19
Meta Platforms (Facebook)
META
$1.47T
$13.2M 1.88%
22,500
BX icon
20
PUT
Blackstone
BX
$107B
$12.9M 1.84%
+75,000
New +$13.1M
IMAX icon
21
IMAX
IMAX
$2.76B
$12.8M 1.82%
500,000
+200,000
+67% +$4.7M
BOOT icon
22
Boot Barn
BOOT
$4.69B
$12.7M 1.8%
+83,400
New +$12.3M
PWR icon
23
Quanta Services
PWR
$90.6B
$12.6M 1.8%
40,000
WDC icon
24
Western Digital
WDC
$166B
$12.5M 1.78%
+277,830
New +$14M
CW icon
25
Curtiss-Wright
CW
$22B
$12.4M 1.77%
35,000

Similar funds

Kingdon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kingdon Capital Management held 103 positions worth $702M, down 22% from $902M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Kingdon Capital Management withdrew a net $80.1M in Q4 2024, closing 33 positions and reducing 18 holdings. Its most notable exit was Abbott, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Kingdon Capital Management opened a new position in Everus Construction Group worth $17.1M.

  • Kingdon Capital Management's largest Q4 2024 buy was Everus Construction Group: 260,000 shares worth $17.1M.
  • Kingdon Capital Management added most to Syndax Pharmaceuticals in Q4 2024, an estimated $17.1M increase.
  • Kingdon Capital Management's biggest Q4 2024 reduction was Insmed, cutting an estimated $12.6M.
  • Kingdon Capital Management fully exited Abbott in Q4 2024, selling an estimated $19.1M.
  • Kingdon Capital Management's ten largest holdings make up 29% of its $702M portfolio in Q4 2024.
  • Kingdon Capital Management opened 24 new positions and closed 33 in Q4 2024.
  • Kingdon Capital Management's portfolio value fell 22% quarter-over-quarter to $702M.

Based on Kingdon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.